ArticleBMJ open2016

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison.

Nick Freemantle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.